Acute ST-segment elevation myocardial infarction is estimated to occur in more than 500,000 people in the US every year. With the introduction of reperfusion therapy by fibrinolysis or primary ...
A number of substudies have been published in 2007, including a Focus Issue of JACC highlighting additional findings from ExTRACT-TIMI 25. In ExTRACT-TIMI 25, women presented with a profile of higher ...
A substantial proportion of patients receiving fibrinolytic therapy for myocardial infarction with ST-segment elevation have inadequate reperfusion or reocclusion of the infarct-related artery, ...
A new study published in the journal of PloS One showed that although reoperative therapy with evolocumab with rosuvastatin ...
Researchers at University Medical Center Maastricht and international partners report that a single shot of the drug zalunfiban given at first medical contact for suspected ST-elevation myocardial ...
TCT 776: Assessment of A Combination of Bedside Lung Ultrasound and Velocity-Time Integral (VTI) to Predict Mortality in ST-Elevation Myocardial Infarction Receive the the latest news, research, and ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
The analysis of four French registries from 1995 to 2010 was presented by Professor Nicolas Danchin from the Hopital Européen Georges Pompidou. Cardiologists recognize two types of myocardial ...
Successful reperfusion following ST-segment elevation myocardial infarction (STEMI) can be achieved using either pharmacologic or mechanical interventions. The goal of reperfusion therapy is to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results